http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016014927-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b7e67c61bd25244a933406ef77319ec
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-04
filingDate 2015-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a17d81c0d9f5ec5ea9442cf7b9e7b5d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b77273919276ad8b1a00540c84d7ecad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fd996c832e0f5182aca11757c478e1b
publicationDate 2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2016014927-A3
titleOfInvention Crystalline form of nicotinamide riboside
abstract Provided are crystalline forms of nicotinamide riboside, including a Form I of nicotinamide riboside chloride according to formula (I). Also disclosed are pharmaceutical compositions comprising the crystalline Form I of nicotinamide riboside chloride, and methods of producing such pharmaceutical compositions. In other aspects, the present disclosure pertains to methods comprising administering to a subject the crystalline Form I of nicotinamide riboside chloride. The present disclosure also provides methods of preparing the crystalline Form I of nicotinamide riboside chloride. Also provided are a crystalline Form I of nicotinamide riboside chloride that is prepared according to any of the disclosed methods for preparing the crystalline Form I.
priorityDate 2014-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011306597-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012329748-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005267023-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005020587-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006229265-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012172584-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008146569-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226674151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID311465843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395240
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66658931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409699548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118050110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID936

Total number of triples: 32.